Quantinuum (NASDAQ:QNT) Stock Gets Price Target Cut from JPMorgan Chase & Co.

Quantinuum (NASDAQ:QNT) had its price target reduced by equities research analysts at JPMorgan Chase & Co. from $97.00 to $80.00 in a research report issued on Friday, Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 112.94% from the stock’s current price.

A number of other brokerages have also recently commented on QNT. Needham & Company LLC cut their price target on shares of Quantinuum from $100.00 to $60.00 and set a “buy” rating for the company in a research note on Friday. Sanford C. Bernstein restated a “hold” rating on shares of Quantinuum in a research note on Wednesday, August 12th. Jefferies Financial Group set a $85.00 target price on shares of Quantinuum in a report on Wednesday, August 12th. Cantor Fitzgerald cut their target price on shares of Quantinuum from $90.00 to $55.00 and set an “overweight” rating for the company in a research note on Friday. Finally, Morgan Stanley upgraded Quantinuum from an “equal weight” rating to an “overweight” rating and reduced their price target for the stock from $78.00 to $62.00 in a report on Thursday, October 15th. Thirteen equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Quantinuum presently has a consensus rating of “Moderate Buy” and an average price target of $87.15.

Quantinuum Price Performance

Shares of NASDAQ QNT traded up $7.75 during trading hours on Friday, hitting $37.57. The company had a trading volume of 5,035,251 shares, compared to its average volume of 2,310,149. The stock has a market capitalization of $9.89 billion and a PE ratio of -134.18. Quantinuum has a 1-year low of $28.31 and a 1-year high of $86.79. The firm’s 50 day moving average price is $43.74.

Quantinuum (NASDAQ:QNT) last released its earnings results on Thursday, November 5th. The company reported ($0.29) earnings per share for the quarter, beating the consensus estimate of ($0.99) by $0.70. The firm had revenue of $9.05 million during the quarter. Equities research analysts expect that Quantinuum will post -4.76 EPS for the current year.

Institutional Investors Weigh In On Quantinuum

Several hedge funds have recently added to or reduced their stakes in the business. CoreCap Advisors LLC bought a new position in Quantinuum in the 3rd quarter valued at about $32,000. Fifth Third Bancorp boosted its holdings in shares of Quantinuum by 1,530.2% during the third quarter. Fifth Third Bancorp now owns 1,027 shares of the company’s stock worth $49,000 after acquiring an additional 964 shares during the period. IFP Advisors Inc grew its position in shares of Quantinuum by 1,150.0% in the third quarter. IFP Advisors Inc now owns 1,250 shares of the company’s stock valued at $60,000 after purchasing an additional 1,150 shares during the last quarter. Steel Grove Capital Advisors LLC grew its position in shares of Quantinuum by 25.6% in the third quarter. Steel Grove Capital Advisors LLC now owns 5,992 shares of the company’s stock valued at $288,000 after purchasing an additional 1,222 shares during the last quarter. Finally, Russell Investments Group Ltd. bought a new position in shares of Quantinuum during the third quarter worth approximately $97,000.

Key Stories Impacting Quantinuum

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Quantinuum beat third-quarter expectations, reporting a loss of $0.29 per share versus the $0.99 loss analysts expected. Revenue rose 233% year over year to $9.05 million, and the company raised its full-year 2026 revenue outlook. The report also noted that gross margin turned positive, although expenses are increasing. Quantinuum Q3 results and outlook
• Positive Sentiment: Commercial traction strengthened: Quantinuum said it secured its largest cloud agreement to date, expanded access through a hyperscaler and an Oracle beta launch, and saw platform adoption rise nearly 20% quarter over quarter. These developments could help build future revenue. Quantinuum Q3 results and outlook
• Positive Sentiment: The company outlined its Nexus developer-platform roadmap, connecting application development with future hardware, including its planned Apollo fault-tolerant quantum computer. The roadmap and reported technical milestones could strengthen Quantinuum’s longer-term competitive position. Nexus roadmap announcement
• Negative Sentiment: Some analysts lowered their forecasts and price targets after the results. Cantor Fitzgerald cut its target from $90 to $55 and Needham lowered its target from $100 to $60, though both retained positive ratings—Overweight and Buy, respectively. The cuts may temper enthusiasm despite the earnings beat. Analysts cut forecasts after Q3 results

Quantinuum Company Profile

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.